in a multicentre study 711 patients were randomised to a group receiving calcium-heparin , 12,500 u , subcutaneously ( 360 ) , or to a group receiving no heparin ( 351 ) , beginning within 24 h of the onset of symptoms .
C0054452
calcium-heparin
C0019134
heparin